Thyroid Gland in Pediatrics — Comprehensive Note Set (Chapter 34)

Fetal development of the thyroid

  • As early as the 10th week of gestation, the fetal thyroid begins synthesizing thyroid hormone

    • Thyroid hormone appears in fetal serum by week 11 and increases throughout gestation

  • Fetal pituitary–thyroid axis largely functions independently of the maternal pituitary–thyroid axis

    • Maternal TSH cannot cross the placenta

    • Maternal thyroid hormone can cross the placenta in limited amounts

  • At birth, there is a TSH surge

    • Peaks at about 70 extmU/L70~ ext{mU/L} within 30 minutes

    • TH levels rise rapidly during the first days of life in response to this TSH surge

    • TSH decreases to childhood levels within a few weeks

  • Physiologic neonatal TSH surge can yield a false‑positive newborn screen for hypothyroidism

    • Blood sampled on the first day of life may show high TSH, prompting concern for congenital hypothyroidism

Physiology

  • Hypothalamic TRH stimulates the anterior pituitary to release TSH

  • TSH stimulates the thyroid to synthesize and release T4T4 and T3T3 via negative feedback involving the hypothalamus, pituitary, and thyroid

  • T4 is the predominant thyroid hormone secreted by the thyroid gland

  • Most circulating T3T3 and T4T4 are bound to thyroxine‑binding globulin (TBG), albumin, and prealbumin; less than 1 ext{%} are in the free form

  • T4T4 is deiodinated in tissues to T3T3, which binds to nuclear thyroid hormone receptors and exerts biologic effects by modifying gene expression

  • Causes of low T4T4 include: hypothyroidism (central or primary), prematurity, malnutrition, and severe illness

  • Total T4T4 is low in conditions that decrease TBG (e.g., familial TBG deficiency, cirrhosis, renal failure) and in patients receiving glucocorticoids or androgens; TSH and FT4 often remain in the normal range

  • Conversely, total T3T3 and T4T4 may be elevated in conditions with increased TBG (congenital TBG excess, pregnancy, estrogen therapy); clinically euthyroid

  • A T3T3 resin uptake (T3RU) helps differentiate between binding protein problems and true hypo‑ or hyperthyroidism

Hypothyroidism (congenital & acquired)

  • Essentials of diagnosis & typical features

    • Growth impairment, decreased physical activity, weight gain, constipation, dry skin, cold intolerance, and delayed puberty

    • Untreated congenital hypothyroidism: thick tongue, large fontanels, poor muscle tone, hoarseness, umbilical hernia, jaundice, and intellectual impairment

    • T4T4, FT4, and T3T3 resin uptake are low; TSH is elevated in primary hypothyroidism

  • General considerations

    • Thyroid hormone deficiency may be congenital or acquired

    • Can be due to defects in the thyroid (primary) or in the hypothalamus/pituitary (central)

Causes of hypothyroidism (Table 34‑4)

  • A. Congenital

    • Aplasia, hypoplasia, or maldescent of the thyroid

    • Inborn errors of thyroid hormone synthesis, secretion, or recycling

    • Maternal antibody‑mediated inhibition of TSH binding to its receptor

    • TSH receptor defect

    • Thyroid hormone receptor defect

    • In utero exposures: radioiodine therapy, goitrogens (e.g., propylthiouracil, methimazole), iodine excess

    • Iodide deficiency

  • B. Acquired (juvenile hypothyroidism)

    • Autoimmune (lymphocytic) thyroiditis

    • Thyroidectomy or radioiodine therapy

    • Irradiation to the thyroid

    • Thyrotropin (TSH) deficiency

    • TRH deficiency due to hypothalamic injury or disease

    • Medications: iodides (excess such as amiodarone; deficiency), lithium, cobalt

    • Large hemangiomas

    • Idiopathic

  • Congenital hypothyroidism occurs in about 1:3000−1:40001{:}3000{-}1{:}4000 infants

  • Untreated congenital hypothyroidism causes severe neurocognitive impairment

  • Most cases are sporadic from hypoplasia/aplasia or failure of migration (e.g., lingual/sub‑lingual thyroid)

  • Severe maternal iodine deficiency results in fetal and maternal T4T4 deficiency with irreversible fetal brain damage

  • Acquired hypothyroidism in childhood is often due to chronic lymphocytic (Hashimoto) thyroiditis

Clinical Findings in hypothyroidism

  • A. Symptoms and signs

    • Newborns: most appear normal even when thyroid is absent; thyroid testing is included in newborn screening due to intellectual impairment risk; jaundice may be present

    • Juvenile hypothyroidism: poor linear growth; delayed bone age and dental eruption; dry, thick, scaly, coarse, pale, cool, or sallow skin; dry or brittle hair; lateral thinning of eyebrows; hypotonia; slow relaxation of deep tendon reflexes; physical and mental slowing; nonpitting myxedema; constipation; cold intolerance; bradycardia; delayed puberty; occasional pseudopuberty (due to weak FSH activity with markedly elevated TSH)

    • In enzymatic defects or autoimmune Hashimoto thyroiditis, the thyroid gland may be enlarged; inchildren with Hashimoto, enlargement is usually symmetrical, moderately firm, and not nodular; Hashimoto thyroiditis may have a cobblestone thyroid surface

  • B. Laboratory findings

    • Primary hypothyroidism: total T4T4 and FT4 may be normal or decreased; serum TSHTSH elevated

    • Circulating autoantibodies to thyroid peroxidase and/or thyroglobulin may be present

    • Central hypothyroidism: TSHTSH is low or inappropriately normal with low T4/FT4T4/FT4; may be associated with other pituitary/hypothalamic deficiencies

  • C. Imaging

    • Thyroid imaging helps establish cause but does not affect treatment; not strictly necessary

    • Bone age is delayed; cardiomegaly is common

  • D. Screening programs for neonatal hypothyroidism

    • All newborns should be screened shortly after birth; screening measures total T4T4 or TSHTSH depending on state

    • Abnormal newborn screening should be confirmed with venous T4T4 and TSHTSH; treatment should start as soon as possible

  • Treatment

    • Synthetic T4T4 (levothyroxine) at 75−100extmcg/extm2/extday75{-}100 ext{ mcg}/ ext{m}^2/ ext{day} is the drug of choice for hypothyroidism

    • In neonates with congenital hypothyroidism, initial dose is 10−15extmcg/extkg/extday10{-}15 ext{ mcg}/ ext{kg}/ ext{day}

    • Serum total T4T4 or FT4 concentrations monitor initial adequacy because neonatal TSH may remain elevated for weeks

    • Subsequently, monitor T4T4 and TSHTSH in combination